|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2007-9-27
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
High-density lipoprotein (HDL) cholesterol levels are a strong inverse predictor of cardiovascular events. However, it is not clear whether this association is maintained at very low levels of low-density lipoprotein (LDL) cholesterol.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2007 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
27
|
|
pubmed:volume |
357
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1301-10
|
|
pubmed:dateRevised |
2009-4-16
|
|
pubmed:meshHeading |
pubmed-meshheading:17898099-Adult,
pubmed-meshheading:17898099-Aged,
pubmed-meshheading:17898099-Anticholesteremic Agents,
pubmed-meshheading:17898099-Apolipoproteins,
pubmed-meshheading:17898099-Cardiovascular Diseases,
pubmed-meshheading:17898099-Cholesterol, HDL,
pubmed-meshheading:17898099-Cholesterol, LDL,
pubmed-meshheading:17898099-Coronary Disease,
pubmed-meshheading:17898099-Double-Blind Method,
pubmed-meshheading:17898099-Female,
pubmed-meshheading:17898099-Heptanoic Acids,
pubmed-meshheading:17898099-Humans,
pubmed-meshheading:17898099-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:17898099-Hypercholesterolemia,
pubmed-meshheading:17898099-Male,
pubmed-meshheading:17898099-Middle Aged,
pubmed-meshheading:17898099-Multivariate Analysis,
pubmed-meshheading:17898099-Pyrroles,
pubmed-meshheading:17898099-Risk
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
|
|
pubmed:affiliation |
Heart Research Institute, Sydney, Australia. barterp@hri.org.au
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
